EFDID: 40261EFD: View Filing

Issuer: ACELRX PHARMACEUTICALS INC (0001427925) - D

Accession: 0001427925-11-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    ACELRX PHARMACEUTICALS INC
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    575 CHESAPEAKE DRIVE
    REDWOOD CITY, CA 94063
  • Persons:
    Related Persons 10
    Richard King
    Executive OfficerDirector
    Pamela P. Palmer
    Executive Officer
    Hamel G. Lawrence
    Executive Officer
    Badri N. Dasu
    Executive Officer
    James H. Welch
    Executive Officer
    Thomas Schreck
    Director
    Stephen J. Hoffman
    Director
    Guy Nohra
    Director
    Howard B. Rosen
    Director
    Mark Wan
    Director
EDGAR: Offering Information
  • Accession Date:
    07/13/2011
  • First Sale Date:
    06/29/2011
  • Offering Amount:
    $20,839,994
  • Amount Sold:
    $20,839,994
  • Exemptions:
    Rule 506
  • Security Type(s):
    Debt
  • Sales Clarification:
    Promissory Notes in which $3,000,000 dollars of which can be converted into Company Common Stock at a fixed conversion price of $5.73; Warrants to purchase Common Stock and Common Stock issuable upon exercise of Warrants and conversion of Promissory Notes
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
ACELRX PHARMACEUTICALS INC/s/ James H. WelchJames H. WelchChief Financial Officer2011-07-13